WeVote
Log In

Bill

Bill

LC 609

Montana pharmacy benefit manager transparency and reform act

2025 Regular Session

Montana bill requiring pharmacy benefit managers to increase transparency in pricing, operations, and conflict-of-interest disclosures died in committee process.

(LC) Draft Died in Process
#professionsandoccupationsgenerally #healthcareservices
0
WeVote Research Nonpartisan
Bill Summary · LC 609

Legislative bill overview

LC 609 would establish transparency requirements and regulatory oversight for pharmacy benefit managers (PBMs) operating in Montana. The bill aims to increase disclosure of PBM practices, pricing mechanisms, and potential conflicts of interest in drug distribution and insurance networks.

Why is this important

PBMs act as intermediaries between insurers, pharmacies, and patients, controlling which drugs are covered and at what price. Lack of transparency in their operations has been linked to higher drug costs, pharmacy closures, and patient access issues. Montana residents and healthcare providers have limited visibility into how PBMs operate, making this regulation potentially significant for drug affordability and pharmacy viability.

Potential points of contention

  • Industry resistance: PBMs argue transparency mandates expose proprietary business practices and could reduce negotiating leverage with pharmaceutical manufacturers
  • Implementation costs: Compliance requirements could increase administrative burden on PBMs, potentially passed to consumers or insurers
  • Scope questions: Uncertainty about whether state-level regulation can effectively address national PBM networks and interstate drug distribution systems

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.